A key point in Farrell’s discussion was the role of glucosamine in pets diagnosed with joint disease. Evaluating current evidence and clinical application, he shared perspectives on its use as a supportive therapy, stressing the need for tailored treatment protocols based on each animal’s specific condition, weight, and pain response.

In his final presentation, Farrell shifted focus to pain management in feline and canine arthritis, addressing both pharmacological and non-pharmacological strategies. He outlined current best practices for controlling chronic pain, emphasizing the importance of quality of life in long-term care. His approach combined clinical rigor with practical strategies that veterinarians can apply directly in practice — particularly in cases where obesity complicates standard treatment paths.

With obesity rates in companion animals rising globally, Farrell’s sessions offered timely, actionable knowledge for veterinarians navigating the complex relationship between excess weight, joint degeneration, and pain management.

As KLIVET 2025 continues to position itself as a leading veterinary congress in the region, contributions like Farrell’s help bridge the gap between emerging clinical challenges and effective, evidence-based solutions in everyday practice.

👉 Watch our full interview with Dr. Mike Farrell on our YouTube channel.